Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) Q3 2021 earnings call dated Jan. 29, 2021 Corporate Participants: Amit Agarwal — Head of Investor Relations Parag Agarwal — Chief Financial Officer Erez Israeli — Chief Executive Officer Analysts: Shanti Patel — Shanti Patel Investment Advisors — Analyst Rashmi Sancheti — InCred Research — Analyst Damayanti Kerai — HSBC Securities and Capital Markets — Analyst Kunal Dhamesha — Emkay Global Financial Services...
Dr. Reddy’s Laboratories Ltd. (RDY) Q3 2021 Earnings Call Transcript
Related Post
- MDT Earnings: Medtronic Q2 FY26 revenue and adj. profit beat estimates
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues and adjusted earnings…
-
Advantage of CERo’s CER receptor lies in native human protein-based antigen binding: CEO
CERo Therapeutics Holdings, Inc. is a biotechnology company pioneering engineered T cell immunotherapies to combat…
-
Viatris (VTRS) posts Q3 2025 results and updates 2025 guidance
Pharmaceuticals company Viatris Inc. (NASDAQ: VTRS) on Thursday reported financial results for the third quarter…